These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 16810071

  • 1. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
    Westfall TC, Naes L, Gardner A, Yang CL.
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):723-8. PubMed ID: 16810071
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y induced modulation of dopamine synthesis in the striatum.
    Adewale AS, Macarthur H, Westfall TC.
    Regul Pept; 2005 Jul 15; 129(1-3):73-8. PubMed ID: 15927700
    [Abstract] [Full Text] [Related]

  • 3. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V, Donoso MV, Brown N, Fanjul R, López C, Fournier A, Huidobro-Toro JP.
    J Pharmacol Exp Ther; 1999 Jun 15; 289(3):1313-22. PubMed ID: 10336522
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF, Malik KU.
    J Pharmacol Exp Ther; 1993 Sep 15; 266(3):1321-9. PubMed ID: 8371140
    [Abstract] [Full Text] [Related]

  • 7. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV, Steiner M, Huidobro-Toro JP.
    J Pharmacol Exp Ther; 1997 Aug 15; 282(2):691-8. PubMed ID: 9262332
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
    Adewale AS, Macarthur H, Westfall TC.
    Neuropharmacology; 2007 May 15; 52(6):1396-402. PubMed ID: 17382974
    [Abstract] [Full Text] [Related]

  • 9. NPY receptor subtype in the rabbit isolated ileum.
    Félétou M, Nicolas JP, Rodriguez M, Beauverger P, Galizzi JP, Boutin JA, Duhault J.
    Br J Pharmacol; 1999 Jun 15; 127(3):795-801. PubMed ID: 10401572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S, Li DL, Simmons RM.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1031-40. PubMed ID: 10215684
    [Abstract] [Full Text] [Related]

  • 12. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat.
    Martin JR.
    Brain Res; 2004 Mar 26; 1002(1-2):11-20. PubMed ID: 14988028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
    Gradin KA, Li JY, Zhu H, Simonsen U.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):118-23. PubMed ID: 18851959
    [Abstract] [Full Text] [Related]

  • 15. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB, Smyth DD, Glavin GB.
    J Pharmacol Exp Ther; 1993 Jul 28; 266(1):339-43. PubMed ID: 8101219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R, Andreis PG, Nussdorfer GG.
    Int J Mol Med; 2005 Jan 28; 15(1):3-13. PubMed ID: 15583821
    [Abstract] [Full Text] [Related]

  • 18. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR, Schober DA, Morin M, Berglund MM.
    Biochem Pharmacol; 2007 Dec 03; 74(11):1652-64. PubMed ID: 17897631
    [Abstract] [Full Text] [Related]

  • 19. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R.
    Br J Pharmacol; 2005 Dec 03; 146(8):1069-81. PubMed ID: 16231000
    [Abstract] [Full Text] [Related]

  • 20. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.
    Dumont Y, Jacques D, Bouchard P, Quirion R.
    J Comp Neurol; 1998 Dec 21; 402(3):372-84. PubMed ID: 9853905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.